Exon 4 Mutations Determination in NOTCH3 Gene for Cryptogenic Ischemic Stroke
Mohamed Lebsir1, Mohamed Larbi Rezgoun 1,2, Boubekeur Saddik Fekraoui 2, Ali Boumegoura3, Brahim Djoudi1, Amina Ines Bernou1, Yacine Benhizia4, Karima Sifi2
Journal of Angiotherapy 8(12) 1-8 https://doi.org/10.25163/angiotherapy.81210123
Submitted: 03 September 2024 Revised: 01 December 2024 Published: 02 December 2024
Abstract
Background: Ischemic stroke in young adults is often classified as cryptogenic (CIS) despite extensive investigation into potential causes. Genetic factors, including mutations in the NOTCH3 gene, are implicated in cerebrovascular diseases such as CADASIL. This study aimed to assess the clinical presentation, vascular risk factors (VRFs), and genetic contributions to CIS in young Algerian adults. Methods: A cross-sectional study was conducted with 42 CIS patients (aged ≤50 years), diagnosed based on the TOAST classification. Data on lifestyle-related VRFs, such as tobacco use and substance consumption, were obtained via interviews. Genotyping was performed on ten single nucleotide polymorphisms (SNPs) in exon 4 of the NOTCH3 gene, a region commonly associated with CADASIL mutations. Results: The mean age of participants was 38.31 ± 8.51 years, with a significant gender difference in age (P = 0.021). Tobacco consumption was a notable risk factor (P = 0.002). However, no mutations were detected in the targeted SNPs of exon 4 of the NOTCH3 gene, either in heterozygous or homozygous states. Conclusion: This suggests that mutations in exon 4 of the NOTCH3 gene may not be involved in the pathogenesis of CIS in this cohort or that unique genetic variants may exist in the Algerian population. The absence of mutations in the analyzed region underlines the need for further research, including comprehensive genetic analysis targeting the entire coding region of the NOTCH3 gene. Larger studies are essential to validate these findings and improve diagnostic, therapeutic, and preventive strategies for CIS in young adults.
Keywords: Cryptogenic ischemic stroke, NOTCH3 gene, CADASIL, young adults, vascular risk factors
References
Boston, G., Jobson, D., Mizuno, T., Ihara, M., & Kalaria, R. N. (2024). Most common NOTCH3 mutations causing CADASIL or CADASIL-like cerebral small vessel disease: A systematic review. Cerebral Circulation-Cognition and Behavior, 100227. https://doi.org/10.1016/j.cccb.2023.100227
Divišová, P., Šanák, D., Král, M., Bártková, A., Hutyra, M., Zapletalová, J., et al. (2020). Young cryptogenic ischemic stroke: A descriptive analysis of clinical and laboratory characteristics, outcomes, and stroke recurrence. Journal of Stroke and Cerebrovascular Diseases, 29(9), 105046. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105046
Dupré, N., Gueniot, F., Domenga-Denier, V., Dubosclard, V., Nilles, C., Hill-Eubanks, D., et al. (2024). Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL. The Journal of Clinical Investigation, 134(8). https://doi.org/10.1172/JCI175789
Ekker, M. S., Verhoeven, J. I., Schellekens, M. M., Boot, E. M., Van Alebeek, M. E., Brouwers, P. J., et al. (2023). Risk factors and causes of ischemic stroke in 1322 young adults. Stroke, 54(2), 439–447. https://doi.org/10.1161/STROKEAHA.122.040524
George, M. G. (2020). Risk factors for ischemic stroke in younger adults: A focused update. Stroke, 51(3), 729–735. https://doi.org/10.1161/STROKEAHA.119.02415
Hack, R. J., Rutten, J., & Lesnik Oberstein, S. A. (1993). CADASIL. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. Updated 2019 Mar 14.
Hu, Y., Sun, Q., Zhou, Y., Yi, F., Tang, H., Yao, L., et al. (2021). NOTCH3 variants and genotype-phenotype features in Chinese CADASIL patients. Frontiers in Genetics, 12, 705284. https://doi.org/10.3389/fgene.2021.705284
Jaakonmäki, N., Zedde, M., Sarkanen, T., Martinez-Majander, N., Tuohinen, S., Sinisalo, J., et al. (2022). Obesity and the risk of cryptogenic ischemic stroke in young adults. Journal of Stroke and Cerebrovascular Diseases, 31(5), 106380.
Karttunen, V., Alfthan, G., Hiltunen, L., Rasi, V., Kervinen, K., Kesäniemi, Y. A., et al. (2002). Risk factors for cryptogenic ischemic stroke. European Journal of Neurology, 9(6), 625–632. https://doi.org/10.1046/j.1468-1331.2002.00464.x
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., et al. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45(7), 2160–2236. https://doi.org/10.1161/STR.00000000000000
Leppert, M. H., Poisson, S. N., Scarbro, S., Suresh, K., Lisabeth, L. D., Putaala, J., et al. (2024). Association of traditional and nontraditional risk factors in the development of strokes among young adults by sex and age group: A retrospective case-control study. Circulation: Cardiovascular Quality and Outcomes, 17(4), e010307.
Li, L., Yiin, G. S., Geraghty, O. C., Schulz, U. G., Kuker, W., Mehta, Z., et al. (2015). Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischemic attack and ischemic stroke: A population-based study. The Lancet Neurology, 14(9), 903–913. https://doi.org/10.1016/S1474-4422(15)00132-5
Martinez Majander, N., Artto, V., Ylikotila, P., von Sarnowski, B., Waje Andreassen, U., Yesilot, N., et al. (2021). Association between migraine and cryptogenic ischemic stroke in young adults. Annals of Neurology, 89(2), 242–253. https://doi.org/10.1002/ana.25954
Mizuta, I., Nakao-Azuma, Y., Yoshida, H., Yamaguchi, M., & Mizuno, T. (2024). Progress to clarify how NOTCH3 mutations lead to CADASIL, a hereditary cerebral small vessel disease. Biomolecules, 14(1), 127. https://doi.org/10.3390/biom14010127
Olesen, K. K., Madsen, M., Gyldenkerne, C., Thrane, P. G., Würtz, M., Thim, T., et al. (2019). Diabetes mellitus is associated with increased risk of ischemic stroke in patients with and without coronary artery disease. Stroke, 50(12), 3347–3354.
Papageorgiou, L., Papa, L., Papakonstantinou, E., Mataragka, A., Dragoumani, K., Chaniotis, D., et al. (2024). SNP and structural study of the Notch superfamily provides insights and novel pharmacological targets against the CADASIL syndrome and neurodegenerative diseases. Genes, 15(5), 529. https://doi.org/10.3390/genes15050529
Papakonstantinou, E., Bacopoulou, F., Brouzas, D., Megalooikonomou, V., D’Elia, D., Bongcam-Rudloff, E., et al. (2019). NOTCH3 and CADASIL syndrome: A genetic and structural overview. EMBnet. Journal, 24. https://doi.org/10.14806/ej.24.0.921
Phipps, M. S., & Cronin, C. A. (2020). Management of acute ischemic stroke. BMJ, 368. https://doi.org/10.1136/bmj.l6983
Ruchoux, M. M., Kalaria, R. N., & Román, G. C. (2021). The pericyte: A critical cell in the pathogenesis of CADASIL. Cerebral Circulation-Cognition and Behavior, 2, 100031. https://doi.org/10.1016/j.cccb.2020.100031
Schulz, U. G. (2019). Cryptogenic stroke—How to make sense of a non-diagnostic entity. Maturitas, 122, 44–50. https://doi.org/10.1016/j.maturitas.2019.01.004
Stack, C. A., & Cole, J. W. (2018). Ischemic stroke in young adults. Current Opinion in Cardiology, 33(6), 594–604.
Takahashi, K., Adachi, K., Yoshizaki, K., Kunimoto, S., Kalaria, R. N., & Watanabe, A. (2010). Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Human Molecular Genetics, 19(1), 79–89. https://doi.org/10.1093/hmg/ddp469
Vera, A., Cecconi, A., Ximenez-Carrillo, A., Ramos, C., Martinez-Vives, P., Lopez-Melgar, B., et al. (2023). Risk of recurrent stroke and mortality after cryptogenic stroke in diabetic patients. Heart and Vessels, 38(6), 817–824.
Wang, J., Hou, L., Lin, J., Zhang, X., Zhang, X., & Liu, X. (2024). Novel mutation of NOTCH3 gene in a Chinese patient with CADASIL: A case report. https://doi.org/10.21203/rs.3.rs-4795632/v1
Wang, W., Gong, Z., Wang, Y., Zhao, Y., Lu, Y., Sun, R., et al. (2024). Mutant NOTCH3 ECD triggers defects in mitochondrial function and mitophagy in CADASIL cell models. Journal of Alzheimer’s Disease, 1–16. https://doi.org/10.3233/JAD-220880
Yaghi, S., Bernstein, R. A., Passman, R., Okin, P. M., & Furie, K. L. (2017). Cryptogenic stroke: Research and practice. Circulation Research, 120(3), 527–540. https://doi.org/10.1161/CIRCRESAHA.116.308447
Yuan, L., Chen, X., Jankovic, J., & Deng, H. (2024). CADASIL: A NOTCH3-associated cerebral small vessel disease. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2024.01.001
Yuan, W. Z., Shang, L., Tian, D. S., Wu, S. W., You, Y., Tian, C. L., et al. (2022). Monogenic basis of young-onset cryptogenic stroke: A multicenter study. Annals of Translational Medicine, 10(9). https://doi.org/10.21037/atm-21-3843
View Dimensions
View Altmetric
Save
Citation
View
Share